LncRNA MALAT1 signaling pathway and clinical applications in overcome on cancers metastasis

Madineh Mazarei1, Venus Shahabi Rabori2, Nazila Ghasemi3

  • 1Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.

PubMed

Insights

Long noncoding RNAs (lncRNAs) like MALAT1 are crucial in cancer. This study explores MALAT1

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer treatment faces challenges due to high mortality and complex signaling pathways.
  • Aberrant gene expression is a hallmark of cancer, necessitating targeted therapies.
  • Long noncoding RNAs (lncRNAs) are emerging as key regulators of gene expression and potential therapeutic targets.

Purpose of the Study:

  • To investigate the functional roles of the lncRNA MALAT1 in cancer metastasis.
  • To elucidate the interactions between MALAT1 and cellular signaling pathways.
  • To highlight MALAT1 as a potential therapeutic target for cancer treatment.

Main Methods:

  • Literature review and analysis of existing research on MALAT1.
  • Examination of MALAT1's involvement in gene expression, RNA processing, and epigenetic control.
  • Analysis of MALAT1's association with cancer cell metastasis, invasion, autophagy, and proliferation.

Main Results:

  • High expression of MALAT1 is linked to increased cancer cell metastasis and invasion.
  • MALAT1 influences multiple signaling pathways and microRNAs (miRNAs) within cancer cells.
  • MALAT1 plays a significant role in regulating gene expression relevant to cancer progression.

Conclusions:

  • MALAT1 is implicated in key processes driving cancer metastasis.
  • Understanding MALAT1's interactions with signaling pathways offers new avenues for cancer therapy.
  • Targeting MALAT1 presents a promising strategy for the diagnosis and treatment of various malignancies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K